SYSTEMIC CARNITINE DEFICIENCY Flashcards

1
Q

naturally occuring amino acid derivative, produced by kidneys and liver

A

systemic carnitine deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

carnitine is synthesized endogenously from essential amino acid ______ with terminal groups donated by _____ (SAM)

A

lysine and s-adenosylmethionine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

systemic carnitine deficiency is a _____ disorder that prevents the body from utilizing fats for energy

A

autosomal recessive disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3 areas of involvement include:

the _______ which is affected by progressive cardiomyopathy

A

cardiac muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 areas of involvement include:

the _______ which is affected by encephalopathy caused by hypoketotic hypoglycemia

A

central nervous system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

3 areas of involvement include

the __________- which is effected by myopathy

A

skeletal muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

autosomal recessive disorder wherein both parents should have defect in SLC22A5 gene which is responsible for carnitine production and OCTN2 mutations impair transporters to plasma membrane

A

primary SCD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

secondary to metabolic disorder

A

secondary SCD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

affects only the liver resulting in reduced fatty acid oxidation and lipid accumulation and ketogenesis with hypoglycemia

A

inherited CPT-2 deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

primary SCD

autosomal recessive disorder wherein both parents should have defect in _______ gene which is responsible for carnitine production and _______ mutations impair transporters to plasma membrane

A

SLC22A5 gene
OCTN2 mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

_____________ - consequence of impaired fatty acid oxidation and lipid accumulation with muscular weakness

A

hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

mutations in the ______ gene cause systemic carnitine deficiency

A

SLC22A5 gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The SLC22A5 gene provides instructions for making protein called _____ that transports carnitine cells

A

OCTN2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

________ serves as a carrier of long chain fatty acids across the mitochondrial membrane

A

carnitine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

in the cytosol FFA are activated by esterification to CoAsh by ______________ synthetase

A

acyl coa synthetase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Net _____ ATP equivalents is consumed to activate 1 FFA to a thioester

A

2 ATP

17
Q

formation of _________ through the enzyme CPT1

A

acylcarnitine

18
Q

formation of acylcarnitine through the enzyme ____________

A

Carnitine palmitoyl transferase-1

19
Q

Formation of Acylcarnitine through the enzyme CPT1

Acylcarnitine will now be transferred to the matrix in exchange for another free carnitine through ______________

A

carnitine acylcarnitine translocase

20
Q

carnitine and fatty acyl CoA liberation

one acylcarnitine is inside the mitochondrial matrix _______ will break down acylcarnitine into carnitine and fatty acyl CoA

A

CPT2

21
Q

most peripheral tissues which normally use fatty acids, become glucose dependent

increased _________

A

gluconeogenesis

22
Q

enzymes located at the outer mitochondrial membrane

A

acyl-coA synthetase
CPT-1

23
Q

enzymes located at the inner mitochondrial membrane

A

carnitine acylcarnitine translocase
CPT-2

24
Q

in the presence of ATP and coenzyme A, the enzyme ___________- catalyzes the conversion of a fatty acid to an “active fatty acid” or acyl-CoA using one high energy phosphate and forming AMP and PP1

A

acyl-coA synthetase (thiokinase)

25
Q

in the presence of ATP and coenzyme A, the enzyme acyl coA synthetase (thiokinase) catalyzes the conversion of a fatty acid to an “active fatty acid” or acyl-CoA using one high energy ___________ and forming AMP and PP1

A

high energy phosphate

26
Q

in the presence of carnitine however ____________, located in the outer mitochondrial membrane, transfers the long chain acyl group from CoA to carnitine, forming acylcarnitine and releasing CoA.

A

Carnitine palmitoyltransferase-I

27
Q

in the presence of carnitine however carnitine palmitoyltransferase-I, located in the outer mitochondrial membrane, transfers the long chain acyl group from CoA to carnitine, forming ____________________.

A

acylcarnitine and releasing CoA

28
Q

acylcarnitine is able to penetrate the inner membrane and gain access to the beta oxidation system of enzymes via the inner membrane exchange transporter ____________

A

carnitine acylcarnitine translocase

29
Q

the acylgroup is then transfered to CoA so that acyl-CoA is reformed and carnitine is liberated. This reaction is catalyzed by ___________

A

carnitine palmitoyl transferase II

30
Q

carnitine palmitoyl transferase II is located on the inside of the _________-

A

inner mitochondrial membrane

31
Q

inherited _________ affects only the Liver, resulting in reduced fatty acid oxyidation and ketogenesis, with hypoglycemia

A

CPTI- deficiency

32
Q

____________ deficiency affects primarily the skeletal muscle and when severe the liver.

A

CPTII deficiency

33
Q

the ___________ drugs (glyburide, glibenclamide and tolbutamide), used in the treatment of type 2 diabetes mellitus, reduce fatty acid oxidation and therefore hyperglycemia by inhibiting CPT-1

A

sulfonylurea drugs